Clinical benefits and costs of an outpatient parenteral antimicrobial therapy service
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 17 (10) , 1758-1763
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A qualitative study of patients’ feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvementBMJ Open, 2018
- Outpatient parenteral antimicrobial therapyBritish Journal of Hospital Medicine, 2018
- Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT serviceInternational Journal of Antimicrobial Agents, 2018
- Outpatient Parenteral Antimicrobial Therapy (OPAT) Practices at a Veterans Affairs Hospital: Potential for Pharmacist ImpactOpen Forum Infectious Diseases, 2017
- Successful outpatient parenteral antibiotic therapy delivery via telemedicineJournal of Antimicrobial Chemotherapy, 2017
- Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in SpainInternational Journal of Antimicrobial Agents, 2017
- The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapyHealth Services and Delivery Research, 2017
- Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy ProgramOpen Forum Infectious Diseases, 2016
- Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: A review of the last decadeInternational Journal of Antimicrobial Agents, 2014
- Cost Analysis of an Adult Outpatient Parenteral Antibiotic Therapy (OPAT) ProgrammePharmacoEconomics, 2000